AngioDynamics (ANGO) Reports In-Line Q4 EPS

AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.14, in-line with the analyst estimate of $0.14. Revenue for the quarter came in at $90.9 million versus the consensus estimate of $91.67 million.

AngioDynamics sees FY2016 EPS of $0.62-$0.66, versus the consensus of $0.59. AngioDynamics sees FY2016 revenue of $364-370 million, versus the consensus of $357.8 million.

AngioDynamics sees Q1 2016 EPS of $0.10-$0.12, versus the consensus of $0.14. AngioDynamics sees Q1 2016 revenue of $83-87 million, versus the consensus of $88.5 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M